A clinical validation study of MammaPrint in hormone receptor-positive breast cancer from the Austrian Breast and Colorectal Cancer Study Group 8 (ABCSG-8) biomarker cohort

BACKGROUND: MammaPrint is a prognostic assay based on gene expression in tumors from patients with early breast cancer. MammaPrint has been extensively validated and Food and Drug Administration cleared in fresh and formalin-fixed and paraffin-embedded (FFPE) tissue. We aimed to assess its prognosti...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubsky, P., Van't Veer, L., Gnant, M., Rudas, M., Bago-Horvath, Z., Greil, R., Lujinovic, E., Buresch, J., Rinnerthaler, G., Hulla, W., Moinfar, F., Egle, D., Herz, W., Dreezen, C., Frantal, S., Filipits, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807937/
https://www.ncbi.nlm.nih.gov/pubmed/33399073
http://dx.doi.org/10.1016/j.esmoop.2020.100006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807937/
https://www.ncbi.nlm.nih.gov/pubmed/33399073
http://dx.doi.org/10.1016/j.esmoop.2020.100006

Ejemplares similares